These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Testing of hemolytic complement components in domestic animals. Barta O; Hubbert NL Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137 [TBL] [Abstract][Full Text] [Related]
27. [Interaction between the complement and the coagulation systems]. Arroyave CM Bol Med Hosp Infant Mex; 1975; 32(2):297-305. PubMed ID: 1138710 [No Abstract] [Full Text] [Related]
28. [Immunologic tests: C6, C7, C8 and C9]. Hatanaka M; Shimizu A Nihon Rinsho; 2005 Jul; 63 Suppl 7():92-4. PubMed ID: 16111197 [No Abstract] [Full Text] [Related]
29. Terminal complement components play a role in the expression of C5a. Gresham HD; Renfer L; Hammer CH; Frank MM J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718 [TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of C6, C7, C9 and C1-INH analysis]. Akagaki Y; Inai S Nihon Rinsho; 1990 Feb; 48 Suppl():662-5. PubMed ID: 2113138 [No Abstract] [Full Text] [Related]
31. The hemolytic equivalence of human, guinea pig and canine complement proteins. Sargent AU; Johnson SB Immunol Commun; 1980; 9(5):453-63. PubMed ID: 6903556 [TBL] [Abstract][Full Text] [Related]
32. Activation of therminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor. Miyama A; Kato T; Minoda I; Ueda T; Kashiba S Jpn J Microbiol; 1976 Dec; 20(6):507-16. PubMed ID: 1035353 [TBL] [Abstract][Full Text] [Related]
33. Functional properties of the asialo-fifth component of human complement. Schultz DR; Arnold PI J Immunol; 1990 Jul; 145(2):655-61. PubMed ID: 2114446 [TBL] [Abstract][Full Text] [Related]
34. [C6, C7, C8 and C9]. Hatanaka M; Shimizu A Nihon Rinsho; 1999 Nov; 57 Suppl():71-4. PubMed ID: 10635778 [No Abstract] [Full Text] [Related]
35. [Immunoenzyme determination of the C5b-9 complex of the complement system]. Rus H; Niculescu F; Cristea A; Vlaicu R Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):35-40. PubMed ID: 3738363 [No Abstract] [Full Text] [Related]
36. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report. Hetland G; Bungum L APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254 [TBL] [Abstract][Full Text] [Related]
37. The structural events associated with the attachment of complement components to cell membranes in reactive lysis. Dourmashkin RR Immunology; 1978 Aug; 35(2):205-12. PubMed ID: 750370 [TBL] [Abstract][Full Text] [Related]
38. Immunologically mediated membrane damage: the mechanism of complement action and the similarity of lymphocyte-mediated cytotoxicity. Mayer MM; Hammer CH; Michaels DW; Shin ML Transplant Proc; 1978 Dec; 10(4):707-14. PubMed ID: 366830 [No Abstract] [Full Text] [Related]
40. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity. Yamamoto KI J Immunol; 1977 Oct; 119(4):1482-5. PubMed ID: 894048 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]